Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 07 03 2024
medline: 18 3 2024
pubmed: 18 3 2024
entrez: 18 3 2024
Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2023.284109 PMID: 38497158
pubmed: 38497158
doi: 10.3324/haematol.2023.284109
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Emilio Iannitto (E)

La Maddalena Department of Oncology, Onco-Hematology and Bone Marrow Transplantation Unit, Palemo, Italy; Tumor Immunology Unit Department of Health Sciences University of Palermo School of Medicine. Istituto di Patologia Generale, Palermo.

Simone Ferrero (S)

Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino.

Côme Bommier (C)

Universitè Paris Citè; AP-HP, Hôpital Saint-Louis, Hemato-oncologie, Paris.

Daniela Drandi (D)

Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino.

Martina Ferrante (M)

Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino.

Krimo Bouabdallah (K)

CHU de Bordeaux - Hôpital Haut Lèvêque and Centre François Magendie, Service d'Hématologie Clinique et Thérapie Cellulaire, Pessac.

Sylvain Carras (S)

Univ. Grenoble Alpes. Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309). University Hospital, Molecular Biology and Hematology departments, Grenoble.

Guido Gini (G)

Ematologia AOU delle Marche, Ancona.

Vincent Camus (V)

Department of Hematology, Centre Henri Becquerel, Rouen.

Salvatrice Mancuso (S)

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), Hematology Unit, University of Palermo.

Luigi Marcheselli (L)

Fondazione Italiana Linfomi ETS, Modena.

Angela Ferrari (A)

Azienda Unità Sanitaria Locale-IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia.

Michele Merli (M)

Hematology, Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi, Varese.

Benoit Tessoulin (B)

Nantes University Hospital and CRC2 NA, Nantes.

Caterina Stelitano (C)

UO Ematologia AO Bianchi-Melacrino-Morelli, Reggio Calabria.

Kheira Beldjord (K)

Universitè Paris Citè.

Giovanni Roti (G)

Dipartimento di Medicina e Chirurgia, Università di Parma, AOU di Parma.

Fabrice Jardin (F)

Ematologia AOU delle Marche, Ancona.

Barbara Castagnari (B)

Department of Hematology, Ravenna hospital, Ravenna.

Francesca Palombi (F)

Hematology Unit, IRCCS Regina Elena National Cancer Institute, Roma.

Lucile Baseggio (L)

Laboratoire d'Hèmatologie Biologique, Groupement Hospitalier Lyon-Sud/Hospices Civils de Lyon.

Alexandra Traverse-Glehen (A)

Service d'Anatomie Pathologique, Groupement Hospitalier Lyon-Sud/Hospices Civils de Lyon.

Claudio Tripodo (C)

Tumor Immunology Unit Department of Health Sciences University of Palermo School of Medicine. Istituto di Patologia Generale, Palermo.

Anna Marina Liberati (AM)

Oncohematology Unit, University of Perugia, Azienda Ospedaliera S.Maria, Terni.

Margherita Parolini (M)

Ematologia Istituto Romagnolo Per Lo studio dei Tumori Dino Amadori, Meldola.

Sara Usai (S)

Ospedale Oncologico A. Businco, Cagliari.

Caterina Patti (C)

U.O.C. di Oncoematologia Ospedali Riuniti Villa Sofia - Cervello, Palermo.

Massimo Federico (M)

CHIMOMO dept. University of Modena and Reggio Emilia.

Maurizio Musso (M)

La Maddalena Department of Oncology, Onco-Hematology and Bone Marrow Transplantation Unit, Palemo.

Marco Ladetto (M)

University of Eastern Piedmont Amedeo Avogadro S.S. Antonio and Biagio and Cesaro Arrigo Hospital, Alessandria.

Emanuele Zucca (E)

IOSI, Oncology Institute of Southern Switzerland and IOR: Institute of Oncology Research IELSG International Extranodal Lymphoma Study, Bellinzona, Switzerland.

Catherine Thieblemont (C)

Universitè Paris Citè; AP-HP, Hôpital Saint-Louis, Hemato-oncologie, Paris.

Classifications MeSH